TrialFuture oncology (London, England)2018

Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.

Adolfo Enrique Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.